Rochester, NY 7/11/2009 1:26:59 AM
Afternoon Shakers - MYRX - Myriad Genetics Announces Completion of Spin Off of Its Research and Pharmaceutical Business
Myriad Pharmaceuticals, Inc.,MYRX
Afternoon Shakers - MYRX - Myriad Genetics Announces Completion of Spin Off of Its Research and Pharmaceutical Business
---
Myriad Pharmaceuticals, Inc.,MYRX
Last Trade: 4.15
Day's Range: 4.00 - 4.40
52wk Range: 3.63 - 7.49
Volume: 378,469
COMPANY "In The News"
Myriad Genetics, Inc. announced today the successful completion of the spin off of Myriad Pharmaceuticals, Inc. and that Myriad Genetics has received a Private Letter Ruling from the Internal Revenue Service that the dividend of common stock of Myriad Pharmaceuticals to Myriad Genetics shareholders qualifies as a tax free distribution for U.S. income tax purposes.
COMPANY DETAILS
Myriad Pharmaceuticals, Inc., a biopharmaceutical company, engages in the research and development of therapeutic drug candidates. The company's activities include identification of drug targets, discovery of molecules, development of drug candidates, and design and execution of clinical programs. It develops four drug candidates that involve in human clinical trials, as well as engages in the research and development of cancer and infectious disease drugs.
---
At WhisperfromWallStreet.com we specialize in understand the markets, particularly the penny stock market and understand what makes penny stocks increase. In a word it is exposure and by that we mean making the investing public aware of a particular stock, via an investor awareness campaign. Our tracking is second to none with our alerts in 2009 producing an average price gain of 80%+. If you'd like to track our results or receive your own alerts based on our experience, sign up now at... WhisperfromWallStreet.com
---
It's important that every investor be aware of our disclaimer which can be read in its entirety :
http://whisperfromwallstreet.com/disclaimer.php
IMPORTANT NOTE: This is not a solicitation to buy or sell any securities. WhisperfromWallStreet.com, nor any of its affiliates are not registered investment advisors or a broker dealers. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
